Fujifilm Previews World's First Glass-Free Digital Radiography Detector at RSNA 2019 Image

FUJIFILM Medical Systems U.S.A., Inc. (Lexington, MA, USA) previewed its new FDR D-EVO III DR detector at the 105th scientific assembly and annual meeting of the Radiological Society of North America (RSNA) held from December 1 – 6, 2019 in Chicago, USA. FUJIFILM Medical Systems, which is part of the FUJIFILM Healthcare portfolio, is a provider of diagnostic imaging products and medical informatics solutions ranging from digital X-ray systems (DR: detectors, mobiles, rooms and 3D mammography), to the comprehensive Synapse Enterprise Imaging portfolio, to full-field digital mammography systems with digital breast tomosynthesis, and computed tomography solutions.

The FDR D-EVO III previewed at RSNA 2019 is FUJIFILM's third-generation digital X-ray detector featuring a sleek, thin design and status as the world's first glass-free DR detector with patented Irradiated Side Sampling (ISS) – also making it the world's lightest 14x17 detector at approximately four pounds. This innovative design removes the traditional glass substrate from the capture layer, eliminating the most fragile layer inside, allowing for a much lighter weight compared to previous models. The FDR D-EVO III 14x17 inch detector incorporates all of the groundbreaking features of the FDR D-EVO II, including its sleek design with smooth and tapered edges for easier positioning, antibacterial nano-coating to help fight against HAIs and a long-lasting battery life.

Additionally, FUJIFILM displayed its full range of DR detectors, including the CALNEO Dual, a 17x17 inch standard cassette sized detector featuring two sensitivity capture layers, coupled with its intelligent energy subtraction processing. A single exposure produces three images; traditional, soft tissue-only, and bone only views. These distinctly different images are expected to be used for visualizing or tracking of lung cancer nodules. The innovative dual capture layer design yields higher definition general X-ray images, enhancing separation accuracy of bone detail and soft tissue.

FUJIFILM also previewed the FDR SE Lite retrofit DR detector at RSNA 2019 that is geared towards bringing DR technology to specialty and small medical practices. Offered as an economical DR solution, the FDR SE Lite DR detector and its companion workstation offer just the right amount of features such as instant image transfer, simplified workflow, and shortened exam times (compared to computed radiography), to meet the unique needs of small practices. Users have the option of upgrading to include Dynamic Visualization II processing which adapts image contrast and density, based on image, thickness and structural recognition.

At RSNA 2019, FUJIFILM also demonstrated its full Synapse portfolio and debut its latest advancement in Enterprise Imaging, Synapse 7x which is a next-generation, secure server-side viewer platform that extends across enterprise imaging areas, bringing diagnostic radiology, mammography and cardiology together through a single, zero footprint platform, and allowing for immediate content interaction regardless of dataset size. Synapse 3D operates natively within the viewer, extending the same advanced visualization across radiology, cardiology, and mammography, eliminating the need for third-party workstations. Synapse 7x is designed to take full advantage of Fujifilm's open AI-enabled platform and use AI results natively within user workflows.

"Fujifilm's Synapse 7x promises to be a game changer for our US healthcare providers. It's a convergence of Fujifilm's server-side technology and was designed to cover all the different areas of diagnostic visualization as well as meet the long-term goal of providing the richest possible visualization layer for an enterprise imaging solution," said Bill Lacy, Vice President of Medical Informatics at FUJIFILM Medical Systems, U.S.A., Inc. "The robust technology is uniquely AI-enabled and integrated, and is presently unrivalled in the marketplace."

Related Links:
FUJIFILM Medical Systems U.S.A., Inc.